Navigation Links
Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
Date:10/8/2008

n women than in men(4).

The exact process by which PAH develops is not known. However, it appears to be associated with a variety of disease processes, including chronic thromboembolic disease (blood clots), connective tissue diseases, congenital heart disease and exposure to external factors including appetite suppressants or infectious diseases such as HIV(3).

1. Novartis has also conducted early stage research with imatinib mesylate

in another non-oncology disease called idiopathic pulmonary fibrosis

(IPF), a condition in which the lungs become scarred over time, making it

more and more difficult to breathe(6). Early clinical trial results in

IPF did not show a significant treatment benefit over placebo, and

clinical trials have therefore been halted.

About Gleevec

Gleevec(R) (imatinib mesylate) tablets are indicated for the treatment of newly diagnosed adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase. Follow-up is limited to 5 years. Gleevec is also indicated for the treatment of patients with Ph+ CML in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha (IFN-alpha) therapy; adult patients with relapsed or refractory Ph+ acute lymphoblastic leukemia (Ph+ ALL); adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene rearrangements; adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-KIT mutation or with c-KIT mutational status unknown; adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFRa fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRa fusion kinase-negative or unknown; adult patients with unresectable, re
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
2. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
3. Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
4. New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
5. Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium
6. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
7. Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimers
8. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
9. Eight-Year Melanoma Remission is Among Early Cancer Treatment Results
10. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , , PISCATAWAY, N.J., Dec. 3 /PRNew... Bulletin Board: MLSS), the recognized leader in a...at it had entered into a joint venture with China ...arm") and Yichang Humanwell Pharmaceutical Co. Ltd...hina (the "PRC"), to develop orthopedic and epidur...
(Date:12/3/2009)... , , MAPLE GROVE, Minn., Dec. 3 /PRNe...nnounced the next phase of its strategic plan for ...(extended release topiramate), an internally devel...5 is being developed with Upsher-Smith,s proprieta...II clinical trial in early 2010 for the adjunctive...
(Date:12/3/2009)... , , ROCHESTER, N.Y., Dec. 3 /PRNewswire-F...), a leading provider of quantitative imaging for ...itled "System and Method for 4D Reconstruction and...n. ,, VirtualScopics, Vice President of Technol...ated, "We are pleased that Japan has recognized th...
Breaking Medicine Technology:Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Upsher-Smith Announces Milestone in Development of CNS Strategy 2VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3HealthFitness President Gregg O Lehman Named to DMAA Board of Directors 58047 1HealthFitness President Gregg O Lehman Named to DMAA Board of Directors 58047 2Small Steps May Speed Recovery in ICU Patients 58045 1Small Steps May Speed Recovery in ICU Patients 58045 2Hormone Therapy for Prostate Cancer Raises Heart Risks 58043 1Hormone Therapy for Prostate Cancer Raises Heart Risks 58043 2
...mprovement in Personal and Social,Performance,...re/ --,Longer-term treatment with INVEGA(TM) (pa... daily oral medication for,schizophrenia, helped...s and maintain their improvements in personal and ...om a large, open label, international,clinical t...
...WIRE)--Mar 30, 2007 - NEOPHARM, Inc.,(Nasdaq: NEOL...trial in second-line metastatic colorectal cancer ...the active metabolite of irinotecan,(Camptosar(R))...,completion of treatment of the first 21 patients ...not achieve the primary tumor,response endpoint. N...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6NeoPharm Provides Update on LE-SN38 Program 2
(Date:12/3/2009)...BO analysis understates key factors contributing t...USNewswire/ -- A new actuarial analysis by Oliver ...ms in the new individual market will be 54 percent...mentation of healthcare reform under the Patient P...ng the impact of medical inflation. This would tr...
(Date:12/3/2009)... Harmful procedures on young women caused by outda...h sues FDA on December 11 for blocking new technol...B) December 2, 2009 -- Now the American College o...at the invasive cancer workup procedure, also know...necessary to some women who have received the proc...
(Date:12/3/2009)...many, PARSIPPANY, N.J. and ANDOVER, Mass., Dec. 3 ...se Image Intelligence® company, and Visage Im... Medicus Ltd. (ASX: PME) announced today that they...p and market advanced oncology solutions for the c...partnership enables Definiens to utilize the Visag...
(Date:12/3/2009)..., N.C., Dec. 3 To honor...th International has created a named award for a ...ident and CEO Pape Gaye presented the inaugural Pa...rize, during a ceremony at the non-profit,s North ...nnual award, IntraHealth seeks to recognize health...
(Date:12/3/2009)... Satori World Medical, a leading global healthcare...el space, announced that international medical qua...s Medical Quality Advisory Board (MQAB). , ..., 2009 –- Satori World Medical, a leading gl...ng medical travel space, announced that internatio...
Breaking Medicine News(10 mins):Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4Health News:Harmful Procedures on Young Women Caused by Outdated HPV test, not by Pap Test 2Health News:Visage Imaging and Definiens Announce Partnership 2Health News:Visage Imaging and Definiens Announce Partnership 3Health News:Inaugural 'Health Worker Leadership Award' Honors Kenyan Midwife, IntraHealth Senior Leader 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 3Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 4
...in C has long been known to give a boost to the bo...and in ensuring good health//. Now, a Christchurch... behind the blessing of Vitamin C, demonstrating t...with a team from the Angiogenesis Research Group a...
...ealand researchers claimed Friday that vitamin C w...cancer by making chemotherapy treatment more effec...sity's Free Radical Research Group, said laborator... a cold. "I've found that vitamin C is absol...
...rch has shown that people who exercise do better o...lly what exercise does within the brain//. Exercis...mpus, known as the dentate gyrus, which underlies ...t-ever observation of neurogenesis, the growth of ...
...al scientists at the University of Leicester and F...n-killing drug//. The composition of the drug and ... on 20th March. Professor David Lambert, who...s many of the side effects of morphine, currently ...
...onvenience to view personal medical records on the...s the core of the novel NHS IT system, slated to s... records, spearheaded by ‘Connecting for Health’ s...his plan will be sent to patients and they will be...
...esearch suggests that a child’s race may be a fact...o toxins associated with environmental tobacco smo...n children with asthma, who are exposed to ETS, ha...co-related disorders, such as asthma, sudden-infan...
Other Medicine News:Health News:Vitamin C Could Help in Curbing Cancer 2Health News:New Reason to Hit the Gym: Fighting Memory Loss 2Health News:Race Affects Tobacco Absorption in Children 2
Premier Thumb Spica
FREEDOM® Memory Thumb Spica
QualCraft™ Gamekeeper Thumb Stabilizer
...dom® CMC ThumbFit™ reduces joint instabi...ofile splint is remarkably comfortable and easy fo... CHT and Robert V. Sypher Jr., MD, FAAOS, develope...plaints of discomfort and impaired hand function f...
Medicine Products: